HCC risk prediction using biomarkers in non-cirrhotic patients following HCV eradication: Reassuring the patient or the doctor? - Sorbonne Université
Article Dans Une Revue JHEP Reports Innovation in Hepatology Année : 2021

Dates et versions

hal-03334459 , version 1 (03-09-2021)

Identifiants

Citer

Charlotte E Costentin, Pierre Nahon. HCC risk prediction using biomarkers in non-cirrhotic patients following HCV eradication: Reassuring the patient or the doctor?. JHEP Reports Innovation in Hepatology, 2021, 3 (4), pp.100320. ⟨10.1016/j.jhepr.2021.100320⟩. ⟨hal-03334459⟩
81 Consultations
29 Téléchargements

Altmetric

Partager

More